LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is 4.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,843,000 | +7.2% | 650,000 | 0.0% | 0.77% | -11.4% |
| Q4 2016 | $4,518,000 | -99.9% | 650,000 | 0.0% | 0.87% | +1.9% |
| Q3 2016 | $5,349,500,000 | +101504.9% | 650,000 | 0.0% | 0.85% | -9.1% |
| Q2 2016 | $5,265,000 | +72.7% | 650,000 | +8.3% | 0.94% | +54.5% |
| Q1 2016 | $3,048,000 | -31.3% | 600,000 | +4.3% | 0.60% | -9.8% |
| Q4 2015 | $4,439,000 | +12.8% | 575,000 | -15.8% | 0.67% | +7.0% |
| Q3 2015 | $3,935,000 | -22.8% | 683,108 | +22.9% | 0.63% | +2.5% |
| Q2 2015 | $5,099,000 | – | 556,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 2,823,333 | $25,890,000 | 96.51% |
| Avoro Capital Advisors LLC | 2,923,065 | $26,805,000 | 7.38% |
| ACUTA CAPITAL PARTNERS, LLC | 886,000 | $8,125,000 | 5.02% |
| Perceptive Advisors | 2,759,593 | $25,305,000 | 1.52% |
| Ghost Tree Capital, LLC | 350,000 | $3,210,000 | 1.04% |
| Broadfin Capital, LLC | 1,812,419 | $16,620,000 | 0.89% |
| P.A.W. CAPITAL CORP | 80,000 | $734,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 556,000 | $5,099,000 | 0.61% |
| Cormorant Asset Management, LP | 499,815 | $4,583,000 | 0.61% |
| Trellus Management Company, LLC | 38,500 | $353,000 | 0.40% |